🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought itRead More

Europe shares hit 3-wk low as S&P cuts US outlook

Published 04/18/2011, 09:52 AM
Updated 04/18/2011, 09:56 AM
NDX
-
US500
-
BARC
-
SOGN
-
BBVA
-
HRGV
-
PMCN
-

* FTSEurofirst 300 down 1.6 percent

* Banks the biggest fallers

* S&P revises U.S. outlook to "negative" from "stable"

By Brian Gorman

LONDON, April 18 (Reuters) - European shares hit a three-week low on Monday after S&P cut its credit outlook for the United States to "negative" from "stable", and as euro zone debt worries resurfaced.

At 1342 GMT, the FTSEurofirst 300 index of top European shares was down 1.6 percent at 1,114.01 points, and had hit is lowest since March 24.

Standard & Poor's on Monday downgraded the outlook for the United States to negative, saying it believes there's a risk U.S. policymakers may not reach agreement on how to address the country's long-term fiscal pressures.

"On a day when sentiment is already weak, the downgrade is not helpful, potentially hastening profit taking. The downgrade also serves to remind investors that whilst the core focus continues to be Europe, significant hurdles for the U.S. remain," said Keith Bowman, equity analyst at Hargreaves Lansdown.

Heavyweight banking fallers included Barclays, BBVA, Societe Generale and UniCredit, down between 4.7 and 5.5 percent.

The European banking index fell 2.7 percent, and the Thomson Reuters Peripheral Banking index was down 4.7 percent, with sentiment knocked by a newspaper report that Greece had asked to restructure its debt. The country's finance ministry denied the report.

Investors also worried that Portugal's bailout negotiations might come under pressure after strong electoral gains for an anti-euro party in Finland that has vowed to veto the pending rescue.

"Concerns about the debt situation in the euro zone periphery are far from behind us, and there is a notion that this bull market since mid 2009 has been largely due to central bank inflationary intervention, which is unsustainable in the long run," a London-based equity trader said.

Among individual companies, Swiss medical device maker Synthes rose 7.3 percent after it said it was in merger talks with Johnson & Johnson.

The Dow Jones, S&P 500 and Nasdaq Composite were down between 1.4 and 1.5 percent in early trade. (Additional reporting by Atul Prakash; Editing by Will Waterman)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.